BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 24163082)

  • 21. The added value of concurrently administered temozolomide versus adjuvant temozolomide alone in newly diagnosed glioblastoma.
    Sher DJ; Henson JW; Avutu B; Hochberg FH; Batchelor TT; Martuza RL; Barker FG; Loeffler JS; Chakravarti A
    J Neurooncol; 2008 May; 88(1):43-50. PubMed ID: 18231723
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Unsuccessful high dose IL-2 therapy followed immediately by near continuous low dose temozolomide can result in rapid durable complete and near-complete remissions in metastatic melanoma.
    Fateh S; Schell TD; Gingrich R; Neves RI; Drabick JJ
    Cancer Biol Ther; 2010 Dec; 10(11):1091-7. PubMed ID: 20930514
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of Temozolomide and Radiotherapy on Brain Metastatic Tumor: A Systematic Review and Meta-Analysis.
    Ma W; Li N; An Y; Zhou C; Bo C; Zhang G
    World Neurosurg; 2016 Aug; 92():197-205. PubMed ID: 27072333
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Radiotherapy with temozolomide provides better survival in the newly diagnosed glioblastoma multiforme: A meta-analysis.
    Wang C; Zhu N; Wang L; An Z
    J Cancer Res Ther; 2015 Oct; 11 Suppl 2():C196-201. PubMed ID: 26506875
    [TBL] [Abstract][Full Text] [Related]  

  • 25. New cytotoxic agents for the treatment of metastatic malignant melanoma: temozolomide and related alkylating agents in combination with guanine analogues to abrogate drug resistance.
    Spiro T; Liu L; Gerson S
    Forum (Genova); 2000; 10(3):274-85. PubMed ID: 11007934
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Randomized trial of the combination of lomeguatrib and temozolomide compared with temozolomide alone in chemotherapy naive patients with metastatic cutaneous melanoma.
    Ranson M; Hersey P; Thompson D; Beith J; McArthur GA; Haydon A; Davis ID; Kefford RF; Mortimer P; Harris PA; Baka S; Seebaran A; Sabharwal A; Watson AJ; Margison GP; Middleton MR
    J Clin Oncol; 2007 Jun; 25(18):2540-5. PubMed ID: 17577032
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Temozolomide associated with PEG-interferon in patients with metastatic melanoma: a multicenter prospective phase I/II study.
    Guillot B; Khamari A; Cupissol D; Delaunay M; Bedane C; Dreno B; Picot MC; Dereure O
    Melanoma Res; 2008 Apr; 18(2):141-6. PubMed ID: 18337651
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Phase II trial of arsenic trioxide and ascorbic acid with temozolomide in patients with metastatic melanoma with or without central nervous system metastases.
    Bael TE; Peterson BL; Gollob JA
    Melanoma Res; 2008 Apr; 18(2):147-51. PubMed ID: 18337652
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Temozolomide for high grade glioma.
    Hart MG; Garside R; Rogers G; Stein K; Grant R
    Cochrane Database Syst Rev; 2013 Apr; 2013(4):CD007415. PubMed ID: 23633341
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Phase II trial of temozolomide (TMZ) plus irinotecan (CPT-11) in adults with newly diagnosed glioblastoma multiforme before radiotherapy.
    Quinn JA; Jiang SX; Reardon DA; Desjardins A; Vredenburgh JJ; Friedman AH; Sampson JH; McLendon RE; Herndon JE; Friedman HS
    J Neurooncol; 2009 Dec; 95(3):393-400. PubMed ID: 19533023
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Temozolomide in radio-chemotherapy combined treatment for newly-diagnosed glioblastoma multiforme: phase II clinical trial.
    Lanzetta G; Campanella C; Rozzi A; Nappa M; Costa A; Fedele F; Innocenzi G; Gagliardi FM; Salvati M; Minniti G; Frati A; Frati L; Vecchione A
    Anticancer Res; 2003; 23(6D):5159-64. PubMed ID: 14981983
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Temozolomide in patients with melanoma brain metastases treated with whole brain irradiation].
    Conill C; Fernández-Ibiza J; Malvehy J; Puig S; Sánchez M; Castel T
    Med Clin (Barc); 2004 Mar; 122(11):413-5. PubMed ID: 15066248
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Combined treatment for non-small cell lung cancer and breast cancer patients with brain metastases with whole brain radiotherapy and temozolomide: a systematic review and meta-analysis.
    Tian J; Luo Y; Xiang J; Tang J
    J Neurooncol; 2017 Nov; 135(2):217-227. PubMed ID: 28726172
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A meta-analysis of temozolomide versus radiotherapy in elderly glioblastoma patients.
    Yin AA; Cai S; Dong Y; Zhang LH; Liu BL; Cheng JX; Zhang X
    J Neurooncol; 2014 Jan; 116(2):315-24. PubMed ID: 24178440
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Using different schedules of Temozolomide to treat low grade gliomas: systematic review of their efficacy and toxicity.
    Lashkari HP; Saso S; Moreno L; Athanasiou T; Zacharoulis S
    J Neurooncol; 2011 Nov; 105(2):135-47. PubMed ID: 21748491
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Response and safety of whole-brain radiotherapy plus temozolomide for patients with brain metastases of non-small-cell lung cancer: A meta-analysis.
    Han J; Qiu M; Su L; Wu C; Cheng S; Zhao Z; Li D; Wang M; Tao W; Du S
    Thorac Cancer; 2021 Dec; 12(23):3177-3183. PubMed ID: 34704360
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Meta-Analysis of the Safety and Efficacy of Interferon Combined With Dacarbazine Versus Dacarbazine Alone in Cutaneous Malignant Melanoma.
    Xin Y; Huang Q; Zhang P; Yang M; Hou XY; Tang JQ; Zhang LZ; Jiang G
    Medicine (Baltimore); 2016 Apr; 95(16):e3406. PubMed ID: 27100429
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The safety of temozolomide in the treatment of malignancies.
    Trinh VA; Patel SP; Hwu WJ
    Expert Opin Drug Saf; 2009 Jul; 8(4):493-9. PubMed ID: 19435405
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of the effectiveness of whole-brain radiotherapy plus temozolomide versus whole-brain radiotherapy in treating brain metastases based on a systematic review of randomized controlled trials.
    Bai GR; An JB; Chu Y; Wang XY; Li SM; Yan KJ; Lü FR; Gu N; Griffin AN; Sun BY; Li W; Wang GC; Zhou SP; Sun H; Liu CX
    Anticancer Drugs; 2016 Jan; 27(1):1-8. PubMed ID: 26426520
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Temozolomide and cisplatin in avdanced malignant melanoma.
    Daponte A; Ascierto PA; Gravina A; Melucci M; Scala S; Ottaiano A; Simeone E; Palmieris G; Comella G
    Anticancer Res; 2005; 25(2B):1441-7. PubMed ID: 15865103
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.